Newsletter

Fibrodysplasia Ossificans Progressiva
With no cure at hand Pharma companies gear up to offer relief to patients suffering from a sporadic connective tissue disease.
Fibrodysplasia Ossificans Progressiva Newsletter

More Whitepapers / Newsletters

Pompe Disease Newsletter
Pompe Disease

An autosomal metabolic disorder – Pompe disease results in deterioration of organs and tissues as a consequence of excess accumulation of glycogen in muscle and nerve cells throughout the body. Also c...

Alzheimer's disease
Alzheimer's disease

Alzheimer's disease is an irreversible, progressive disorder of the brain that progressively destroys memory and thinking skills of an individual. It is the most common cause of dementia (a continuous...

Fragile X Syndrome Newsletter
Fragile X Syndrome

Fragile X Syndrome is a syndrome, which results in intellectual disabilities as well as affects the physical characteristics of the people, and is a result of mutation associated with the gene FMR1. D...

Value-Based Healthcare
Value-Based Healthcare

Value-Based Healthcare is that healthcare model or a process where the providers, including hospitals and physicians are paid based on patient health outcomes. It is one of the alternative models that...

Biosimilars: Evidence From Europe
Biosimilars: Evidence From Eur...

The EU market contains more than 55 biosimilars for around 15 oncology, autoimmune, diabetes, and fertility biologic therapies. Although the expiry of patent protection for biologics has resulted in i...